Anna van Rhenen

The novel AML stem cell–associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells

Anna van Rhenen, Guus A.M.S. van Dongen, Angèle Kelder et al. · Blood · 2007 · 434 citations · Full text

Medicine, Hematology, Oncology +10

High Stem Cell Frequency in Acute Myeloid Leukemia at Diagnosis Predicts High Minimal Residual Disease and Poor Survival

Anna van Rhenen, N Feller, Angèle Kelder et al. · Clinical Cancer Research · 2005 · 372 citations · Full text

Medicine, Hematology, Oncology +14

Aberrant marker expression patterns on the CD34+CD38− stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission

Anna van Rhenen, Bijan Moshaver, Angèle Kelder et al. · Leukemia · 2007 · 191 citations

Medicine, Hematology, Oncology +17

Identification of a Small Subpopulation of Candidate Leukemia-Initiating Cells in the Side Population of Patients with Acute Myeloid Leukemia

Bijan Moshaver, Anna van Rhenen, Angèle Kelder et al. · Stem Cells · 2008 · 95 citations · Full text

Medicine, Cell Biology, Hematology +17

Fludarabine exposure in the conditioning prior to allogeneic hematopoietic cell transplantation predicts outcomes

Jurgen Langenhorst, Charlotte van Kesteren, Erik M. van Maarseveen et al. · Blood Advances · 2019 · 76 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17